These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 54744)

  • 41. Treatment of ventricular arrhythmias.
    Lancet; 1971 Oct; 2(7729):857-8. PubMed ID: 4106879
    [No Abstract]   [Full Text] [Related]  

  • 42. Myocardial metabolic changes related to ventricular fibrillation.
    Hjalmarson A
    Cardiology; 1980; 65(4):226-47. PubMed ID: 6248218
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anion manipulation, a novel antiarrhythmic approach: mechanism of action.
    Curtis MJ; Garlick PB; Ridley PD
    J Mol Cell Cardiol; 1993 Apr; 25(4):417-36. PubMed ID: 8393492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclic nucleotides concentrations in the canine heart with regional ischemia. The role of cyclic AMP in ventricular fibrillation and the effect of dibutyryl cyclic AMP.
    Ukai M; Ogawa K
    Jpn Circ J; 1984 Mar; 48(3):247-52. PubMed ID: 6323779
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prevention of ventricular fibrillation in animal experiments].
    Doshchitsin VL; Pozin VM; Skuratovskaia SG; Gendlin GE; Fedorova IF
    Kardiologiia; 1978 Apr; 18(4):73-5. PubMed ID: 671971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiarrhythmic drugs in resuscitation.
    Chamberlain DA
    Heart; 1998 Oct; 80(4):408-11. PubMed ID: 9875125
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of BN 52256 and other mediator antagonists on ouabain-induced ventricular fibrillation in sensitized guinea-pigs and on ischemia-induced fibrillation in rats.
    Mest HJ; Rein T; Riedel A; Köpernik W; Braquet C
    Agents Actions Suppl; 1992; 37():228-34. PubMed ID: 1632298
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Secondary prevention of myocardial infarct with anti-arrhythmia drugs and beta receptor blockaders].
    Mösslacher H
    Wien Med Wochenschr; 1984 Dec; 134(23-24):566-72. PubMed ID: 6152091
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Newer antiarrhythmic agents for patients with coronary artery disease.
    Schroeder JS
    Angiology; 1978 Jan; 29(1):22-32. PubMed ID: 343649
    [No Abstract]   [Full Text] [Related]  

  • 50. Ventricular tachyarrhythmias in regional myocardial hyperkalemia: efficacy of three antiarrhythmic agents.
    Ettinger PO; Moore RJ; Calabro J; Oldewurtel HA; Regan TJ
    J Electrocardiol; 1980 Apr; 13(2):153-7. PubMed ID: 7365356
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Role of antiarrhythmics in the post-infarction period].
    Dinanian S
    Arch Mal Coeur Vaiss; 2000 Apr; 93(3 Spec No):65-9. PubMed ID: 10816803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiarrhythmic effects of BN-063, a newly synthesized adenosine A1 agonist, on myocardial ischaemia in rats.
    Lee YM; Chern JW; Yen MH
    Br J Pharmacol; 1994 Aug; 112(4):1031-6. PubMed ID: 7952861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The selection of antiarrhythmic regimens by electrophysiologic studies: techniques and results.
    Horowitz LN; Spielman SR; Greenspan AM; Webb CR
    Cardiovasc Clin; 1985; 15(3):187-97. PubMed ID: 2870804
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effect of prophylactic antiarrhythmic treatment on the incidence of ventricular arrhythmias in the postinfarction period (author's transl)].
    Wolf R; Sinn R; Guillen R
    Z Kardiol; 1982 Jan; 71(1):26-30. PubMed ID: 6175118
    [No Abstract]   [Full Text] [Related]  

  • 55. Calcium antagonists, ventricular fibrillation, and enzyme release in ischemic rat hearts.
    Opie LH; Thandroyen FT
    Fed Proc; 1983 May; 42(8):2465-9. PubMed ID: 6132839
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The treatment of ventricular arrhythmias in acute myocardial infarction.
    Adgey AA; Webb SW
    Br J Hosp Med; 1979 Apr; 21(4):356, 358-60, 365-6 passim. PubMed ID: 435675
    [No Abstract]   [Full Text] [Related]  

  • 57. Amiodarone and reperfusion ventricular fibrillation.
    Ayoub CM; Sfeir PM; El-Khatib MF
    J Cardiothorac Vasc Anesth; 2011 Feb; 25(1):207. PubMed ID: 20188593
    [No Abstract]   [Full Text] [Related]  

  • 58. [Primary ventricular fibrillation during the acute phase of myocardial infarction (author's transl)].
    Bernard R; Vainsel H; Dereume G; de Hemptinne J; Smets P; Englert M
    Ann Cardiol Angeiol (Paris); 1978 Nov; 27(6):463-5. PubMed ID: 749677
    [No Abstract]   [Full Text] [Related]  

  • 59. [Relationship among myocardial norepinephrine, cyclic AMP and ventricular fibrillation in experimental infarction].
    Ogawa K; Kanayama H; Ban M; Satake T
    Kokyu To Junkan; 1985 Nov; 33(11):1305-10. PubMed ID: 3006199
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of antiarrhythmic drugs on ventricular fibrillation thresholds of normal and ischaemic myocardium in the anaesthetized rat.
    Marshall RJ; Muir AW; Winslow E
    Br J Pharmacol; 1983 Jan; 78(1):165-71. PubMed ID: 6824812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.